Population Pharmacokinetics of Therapeutic Monoclonal Antibodies

This publication has 92 references indexed in Scilit:

• Biodistribution Mechanisms of Therapeutic Monoclonal Antibodies in Health and Disease
  The AAPS Journal, 2009
• Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
  European Journal of Clinical Pharmacology, 2009
• Denosumab: an investigational drug for the management of postmenopausal osteoporosis
  Biologics: Targets and Therapy, 2008
• Integrated Cellular Bone Homeostasis Model for Denosumab Pharmacodynamics in Multiple Myeloma Patients
  The Journal of Pharmacology and Experimental Therapeutics, 2008
• Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab
  Biologics: Targets and Therapy, 2008
• Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
  Journal of Clinical Oncology, 2008
• Population pharmacokinetic data analysis of three phase I studies of matuzumab, a humanised anti-EGFR monoclonal antibody in clinical cancer development
  British Journal of Cancer, 2008
• Population pharmacokinetics–pharmacodynamics of alemtuzumab (Campath^®) in patients with chronic lymphocytic leukaemia and its link to treatment response
  British Journal of Clinical Pharmacology, 2007
• A mechanism‐based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab
  British Journal of Clinical Pharmacology, 2007
• Kinetics of FcRn-mediated recycling of IgG and albumin in human: Pathophysiology and therapeutic implications using a simplified mechanism-based model
  Published by Elsevier ,2006